Small Molecules Targeting Viral RNA
- PMID: 37686306
- PMCID: PMC10487773
- DOI: 10.3390/ijms241713500
Small Molecules Targeting Viral RNA
Abstract
The majority of antivirals available target viral proteins; however, RNA is emerging as a new and promising antiviral target due to the presence of highly structured RNA in viral genomes fundamental for their replication cycle. Here, we discuss methods for the identification of RNA-targeting compounds, starting from the determination of RNA structures either from purified RNA or in living cells, followed by in silico screening on RNA and phenotypic assays to evaluate viral inhibition. Moreover, we review the small molecules known to target the programmed ribosomal frameshifting element of SARS-CoV-2, the internal ribosomal entry site of different viruses, and RNA elements of HIV.
Keywords: IRES; RNA; SARS-CoV-2; antiviral; programmed ribosomal frameshift.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting.Antiviral Res. 2022 Dec;208:105452. doi: 10.1016/j.antiviral.2022.105452. Epub 2022 Oct 29. Antiviral Res. 2022. PMID: 36341734 Free PMC article.
-
The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting.Nat Commun. 2021 Dec 10;12(1):7193. doi: 10.1038/s41467-021-27431-0. Nat Commun. 2021. PMID: 34893599 Free PMC article.
-
Targeting Ribosomal Frameshifting as an Antiviral Strategy: From HIV-1 to SARS-CoV-2.Acc Chem Res. 2021 Sep 7;54(17):3349-3361. doi: 10.1021/acs.accounts.1c00316. Epub 2021 Aug 17. Acc Chem Res. 2021. PMID: 34403258 Review.
-
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.Science. 2021 Jun 18;372(6548):1306-1313. doi: 10.1126/science.abf3546. Epub 2021 May 13. Science. 2021. PMID: 34029205 Free PMC article.
-
Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.Biochem Soc Trans. 2021 Feb 26;49(1):341-352. doi: 10.1042/BST20200670. Biochem Soc Trans. 2021. PMID: 33367597 Free PMC article. Review.
Cited by
-
Energy landscapes of homopolymeric RNAs revealed by deep unsupervised learning.Biophys J. 2024 May 7;123(9):1152-1163. doi: 10.1016/j.bpj.2024.04.003. Epub 2024 Apr 3. Biophys J. 2024. PMID: 38571310 Free PMC article.
-
Tying the knot: Unraveling the intricacies of the coronavirus frameshift pseudoknot.PLoS Comput Biol. 2024 May 7;20(5):e1011787. doi: 10.1371/journal.pcbi.1011787. eCollection 2024 May. PLoS Comput Biol. 2024. PMID: 38713726 Free PMC article.
-
Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition.RNA Biol. 2024 Jan;21(1):1-18. doi: 10.1080/15476286.2024.2433830. Epub 2024 Dec 4. RNA Biol. 2024. PMID: 39630134 Free PMC article. Review.
-
Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery.Molecules. 2024 Dec 5;29(23):5748. doi: 10.3390/molecules29235748. Molecules. 2024. PMID: 39683906 Free PMC article. Review.
-
Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening.J Chem Inf Model. 2024 Aug 12;64(15):6190-6196. doi: 10.1021/acs.jcim.4c00758. Epub 2024 Jul 22. J Chem Inf Model. 2024. PMID: 39037082 Free PMC article.
References
-
- Cox M., Peacock T.P., Harvey W.T., Hughes J., Wright D.W., Consortium C.-G.U., Willett B.J., Thomson E., Gupta R.K., Peacock S.J., et al. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat. Rev. Microbiol. 2023;21:112–124. doi: 10.1038/s41579-022-00809-7. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous